| Stock Price Performance - 12 Largest Negative Opening Gaps | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Day of Event |
After Event Date (Not Including Day of Selected Event) |
||||||||||||||||
| Date | Note | Day-Of Move | Opening Gap | % Open-to-High | % Open-to-Low | Drift Open-to-Close | 1 Day | 2 Days | 3 Days | 1 Week | 2 Weeks | ||||||
| 19-Nov-2025 |
Press Release Agios Announces Topline Results from RISE UP Phase 3 Trial of Mitapivat in Sickle Cell Disease (19-Nov-2025, 7:00 AM Globe Newswire) HeadlineAgios falls after mixed data from late-stage trial for sickle cell therapy (19-Nov-2025, 12:00 AM Seeking Alpha News) |
-50.9% | |||||||||||||||
| 4-Sep-2025 |
Press Release Agios Provides Update on U.S. PDUFA Goal Date for PYRUKYND (mitapivat) in Thalassemia (4-Sep-2025, 7:00 AM Globe Newswire) HeadlineAgios drops as FDA delays review of thalassemia drug (4-Sep-2025, 12:00 AM Seeking Alpha News) |
-11.0% | |||||||||||||||
| 4-Aug-2025 |
Press Release Agios' PYRUKYND (mitapivat) Approved for Adults with Thalassemia in Saudi Arabia (4-Aug-2025, 4:01 PM Globe Newswire) HeadlineAgios falls as Leerink cites deaths linked to lead asset Pyrukynd (4-Aug-2025, 12:00 AM Seeking Alpha News) |
+3.3% | |||||||||||||||
| 10-Apr-2025 | Market Gap DownSPY had a large negative gap on the day of -3.0% | -3.7% | |||||||||||||||
| 7-Apr-2025 | Market Gap DownSPY had a large negative gap on the day of -3.2% | +0.5% | |||||||||||||||
| 3-Apr-2025 | Market Gap DownSPY had a large negative gap on the day of -3.5% | -2.6% | |||||||||||||||
| 11-Feb-2025 | -3.9% | ||||||||||||||||
| 3-Feb-2025 | Market Gap DownSPY had a large negative gap on the day of -1.5% | -2.3% | |||||||||||||||
| 9-Dec-2024 |
Press Release Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat (8-Dec-2024, 12:40 PM Globe Newswire) HeadlineAgios reports results from late-stage study of its thalassemia treatment (9-Dec-2024, 12:00 AM Seeking Alpha News) |
-21.1% | |||||||||||||||
| 27-Sep-2024 |
Headline Agios cut at Leerink on overhang from Pfizer’s Oxbryta withdrawal (27-Sep-2024, 12:00 AM Seeking Alpha News) |
-5.1% | |||||||||||||||
| 5-Aug-2024 | Market Gap DownSPY had a large negative gap on the day of -4.0% | -3.1% | |||||||||||||||
| 2-Aug-2024 | Day After EarningsAGIO released earnings 1-Aug-2024 BMOMarket Gap DownSPY had a large negative gap on the day of -1.4% | -1.2% | |||||||||||||||
| Simple Average Returns - 12 Largest Negative Opening Gaps | |||||||||||||||||
| Avg Return | |||||||||||||||||
| Positive Occurrences | |||||||||||||||||
| Negative Occurrences | |||||||||||||||||
| Absolute Average Returns - 12 Largest Negative Opening Gaps | |||||||||||||||||
| Abs Avg Return | |||||||||||||||||
| Max Abs Return | |||||||||||||||||
| Min Abs Return | |||||||||||||||||
| Median, Minimum, and Maximum Returns - 12 Largest Negative Opening Gaps | |||||||||||||||||
| Median Return | |||||||||||||||||
| Max Positive Return | |||||||||||||||||
| Max Negative Return | |||||||||||||||||